Global X ETFs Global X Telemedicine & Digital Health UCITS ETF (EDOC)
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
n/a
n/a
$8.43
London
$8.06
n/a
$6.76
$16.31M
$0.07 (0.91%) Previous:
$0.07
n/a
n/a
USD
ETP Basics
| Issuer: | Global X ETFs ICAV |
|---|---|
| Structure: | ETF |
| Replication method: | Stocks - Full Replication |
| Securities lending: | No |
| Number of holdings: | 40 |
| Size: | $16.3M |
| Launch date: | 17 December 2020 |
| Launch price: | n/a |
| UCITS: | Yes |
| Reporting status: | Yes |
| Domicile: | Ireland |
| Complex product: | Non-complex |
| ISIN: | IE00BLR6QB00 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
| Index: | The Index aims to provide exposure to exchange-listed companies that are positioned to benefit from advances and application of advances in the field of telemedicine and digital health (collectively “Telemedicine & Digital Health Companies”). A company must derive at least 50% of its revenue, operating income, or assets from telemedicine and/or digital health to be considered for inclusion in the Index. Telemedicine and Digital Health Companies include those involved in the following business activities (i) telemedicine, (ii) healthcare analytics, (iii) connected healthcare devices and/or (iv) administrative digitisation. |
|---|---|
| Aim: |
The Global X Telemedicine & Digital Health UCITS ETF (EDOC) seeks to invest in...
Read full aim for Global X ETFs |
| Leverage: | 100% |
| Currency hedging: | n/a |
COSTS
| Ongoing Charge (OCF/TER): | 0.68% |
|---|---|
| Management fee: | 0.68% |
| Indicative spread: | 0.7% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
| 1 week 1W | 1.31% | 1 year 1Y | 0.91% |
|---|---|---|---|
| 1 month 1M | 3.08% | 2 years 2Y | 14.96% |
| 3 months 3M | 3.81% | 3 years 3Y | 39.36% |
| 6 months 6M | 10.78% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
| Security | Weight |
|---|---|
| MEDLEY INC | 42.34% |
| ALIBABA HEALTH INFORMATION TECH LTD | 13.85% |
| JD HEALTH INTL INC | 12.90% |
| PING AN HEALTHCARE & TECHNO CO LTD | 4.86% |
| RESMED INC | 1.69% |
| MASIMO CORP | 1.63% |
| DOXIMITY INC | 1.55% |
| DEXCOM | 1.44% |
| AGILENT TECHNOLOGIES INC | 1.23% |
| LABORATORY CORP OF AMERICA HLDGS | 1.19% |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.